MrKyle Greenland

Dr Kyle Greenland is a Postdoctoral Research Associate in the Androgen Signalling and Prostate Cancer Group. His research focuses on tumour fibrosis and therapeutic resistance, with a particular interest in remodelling and “re-priming” the tumour microenvironment to improve response to clinically approved therapies, including chemotherapy. His current work explores angiotensin pathway blockade as a strategy to remodel the tumour microenvironment, enhance drug delivery, and overcome treatment resistance in advanced prostate cancer.

Alongside his academic research, Kyle is the Co-Founder of STEMaccess, an education consultancy providing expert STEM tuition and mentoring. He is passionate about widening access to STEM education and supporting students from diverse backgrounds to build confidence and succeed in competitive pathways.